Philipp Yu

Dr. Philipp Yu


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1996 in Immunity
Verified
Journal Article
Closed access
MKMasahito Kamanaka
Masahito Kamanaka
PYPhilipp Yu
Philipp Yu
TYTeruhito Yasui
Teruhito Yasui
KYKenji Yoshida
Kenji Yoshida
TKTsutomu Kawabe
Tsutomu Kawabe
HKHitoshi Kikutani
Hitoshi Kikutani

1 November 2012 in Immunity
Verified
Journal Article
Closed access
PYPhilipp Yu
Philipp Yu
WLWolger Lübben
Wolger Lübben
HSHeike Slomka
Heike Slomka
JGJanine Gebler
Janine Gebler
MKMadlen Konert
Madlen Konert
SBStefan Bauer
Stefan Bauer

30 June 1994 in Nature
Verified
Journal Article
Closed access
PDF file
PYPhilipp Yu
Philipp Yu
MKMarie Kosco-Vilbois
Marie Kosco-Vilbois
MRMark Richards
Mark Richards
GKGeorges Köhler
Georges Köhler
MLMarinus C. Lamers
Marinus C. Lamers

1 April 2005 in Immunity
Verified
Journal Article
Closed access
PYPhilipp Yu
Philipp Yu
RCRainer Constien
Rainer Constien
NDNeil Dear
Neil Dear
MKMatilda Katan
Matilda Katan
PHPetra Hanke
Petra Hanke
GMGeert C. Mudde
Geert C. Mudde

23 June 2006 in International Immunology
Verified
Journal Article
Open access
PDF file
PYPhilipp Yu
Philipp Yu
UWUte Wellmann
Ute Wellmann
SKSandra Kunder
Sandra Kunder
LQLeticia Quintanilla-Martinez
Leticia Quintanilla-Martinez
LJLuise Jennen
Luise Jennen
HWHermann Wagner
Hermann Wagner
The generation of anti-DNA auto-antibodies is characteristic for the human autoimmune condition systemic lupus erythematosus (SLE) and its animal models. However, the contribution of the toll-like receptor (TLR) system of innate immunity receptors and, in particular, TLR9 to this B cell-mediated autoimmune process remains controversial. Here we report that in a novel murine model of SLE, based on hyper-reactive B cell activation mediated by mutant phospholipase Cg2, the genetic deficiency of TLR9 does not protect from spontaneous anti-DNA auto-antibody formation and glomerulonephritis. On the contrary, disease induction is aggravated and additional nucleolar antibody specificity develops in autoimmune TLR9-deficient mice. In vitro studies demonstrate that, in autoimmune-prone mice, dual signaling via the B cell receptor and non-CpG DNA results in synergistic B cell activation in a TLR9-independent manner. These results suggest that engagement of a TLR9-independent DNA activation pathway may promote autoimmunity, while TLR9 signaling can ameliorate SLE-like immune pathology in vivo.

29 June 2018 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SGSimon Le Gallou
Simon Le Gallou
ZZZhicheng Zhou
Zhicheng Zhou
LTLan-Huong Thai
Lan-Huong Thai
RFRémi Fritzen
Rémi Fritzen
AAAlba Verge de Los Aires
Alba Verge de Los Aires
CRClaude-Agnès Reynaud
Claude-Agnès Reynaud
To what extent immune responses against the gut flora are compartmentalized within mucosal tissues in homeostatic conditions remains a much-debated issue. We describe here, based on an inducible AID fate-mapping mouse model, that systemic memory B cell subsets, including mainly IgM+ B cells in spleen, together with IgA+ plasma cells in spleen and bone marrow, are generated in mice in the absence of deliberate immunization. While the IgA component appears dependent on the gut flora, IgM memory B cells are still generated in germ-free mice, albeit to a reduced extent. Clonal relationships and renewal kinetics after anti-CD20 treatment reveal that this long-lasting splenic population is mainly sustained by output of B cell clones persisting in mucosal germinal centers. IgM-secreting hybridomas established from splenic IgM memory B cells showed reactivity against various bacterial isolates and endogenous retroviruses. Ongoing activation of B cells in gut-associated lymphoid tissues thus generates a diversified systemic compartment showing long-lasting clonal persistence and protective capacity against systemic bacterial infections.